Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.

Article  Google Scholar 

Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular diseases and Risk factors: 2020 and Beyond. J Am Coll Cardiol. 2019;74(20):2529–32.

Article  PubMed  Google Scholar 

Turk-Adawi K, Sarrafzadegan N, Fadhil I, Taubert K, Sadeghi M, Wenger NK, et al. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol. 2018;15(2):106–19.

Article  PubMed  Google Scholar 

Ramezankhani A, Azizi F, Hadaegh F, Eskandari F. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: a population-based prospective study. Atherosclerosis. 2017;263:249–56.

Article  CAS  PubMed  Google Scholar 

Chia CW, Egan JM, Ferrucci L. Age-related changes in glucose metabolism, hyperglycemia, and Cardiovascular Risk. Circ Res. 2018;123(7):886–904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenblit PD. Correction to: Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition. Curr Diab Rep. 2019;19(11):123.

Article  PubMed  Google Scholar 

Mosenzon O, Alguwaihes A, Leon JLA, Bayram F, Darmon P, Davis TME, et al. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol. 2021;20(1):154.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meigs JB, Nathan DM, D’Agostino RB, Sr., Wilson PW, Framingham Offspring S. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care. 2002;25(10):1845–50.

Article  PubMed  Google Scholar 

Brutsaert EF, Shitole S, Biggs ML, Mukamal KJ, deBoer IH, Thacker EL, et al. Relations of Postload and fasting glucose with Incident Cardiovascular Disease and Mortality Late in Life: the Cardiovascular Health Study. J Gerontol Biol Sci Med Sci. 2016;71(3):370–7.

Article  CAS  Google Scholar 

Decode Study Group tEDEG. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–405.

Article  Google Scholar 

Emerging Risk Factors C, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.

Article  Google Scholar 

Sung J, Song YM, Ebrahim S, Lawlor DA. Fasting blood glucose and the risk of stroke and myocardial infarction. Circulation. 2009;119(6):812–9.

Article  PubMed  Google Scholar 

Bragg F, Li L, Smith M, Guo Y, Chen Y, Millwood I, et al. Associations of blood glucose and prevalent diabetes with risk of cardiovascular disease in 500 000 adult Chinese: the China Kadoorie Biobank. Diabet Med. 2014;31(5):540–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ning F, Zhang L, Dekker JM, Onat A, Stehouwer CD, Yudkin JS, et al. Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range. Cardiovasc Diabetol. 2012;11:76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ning F, Tuomilehto J, Pyorala K, Onat A, Soderberg S, Qiao Q, et al. Cardiovascular disease mortality in europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care. 2010;33(10):2211–6.

Article  PubMed  PubMed Central  Google Scholar 

Bozorgmanesh M, Hadaegh F, Saadat N, Azizi F. Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study. Acta Diabetol. 2012;49(5):341–8.

Article  CAS  PubMed  Google Scholar 

Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):1–15.

Article  Google Scholar 

Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15–26.

Article  CAS  PubMed  Google Scholar 

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.

Article  CAS  PubMed  Google Scholar 

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. Seventh report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.

Article  CAS  PubMed  Google Scholar 

Rubinstein A. National Cholesterol Education Program, second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Circulation. 1995;91(3):908–9.

CAS  PubMed  Google Scholar 

Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012;12:117.

Article  PubMed  PubMed Central  Google Scholar 

Hadaegh F, Harati H, Ghanbarian A, Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study. Eur J Cardiovasc Prev Rehabil. 2006;13(4):571–7.

Article  PubMed  Google Scholar 

Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population. Cardiovasc Diabetol. 2010;9(1):84.

Article  PubMed  PubMed Central  Google Scholar 

Hosseinpour-Niazi S, Afaghi S, Hadaegh P, Mahdavi M, Farhadnejad H, Tohidi M et al. The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status. J Diabetes Investig. 2023.

Bollinger G. Book Review: Regression Diagnostics: identifying Influential Data and sources of Collinearity. J Mark Res. 1981;18(3):392–3.

Google Scholar 

Succurro E, Marini MA, Grembiale A, Lugara M, Andreozzi F, Sciacqua A, et al. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Diabetes Metab Res Rev. 2009;25(4):351–6.

Article  CAS  PubMed  Google Scholar 

Wang R, Fu J, Wang A, Zhang X, Wei K, Fu X et al. Increased two-hour post-load plasma glucose fluctuation corresponds with worse clinical prognoses among Acute ischemic stroke patients without a history of diabetes Mellitus. Cerebrovasc Dis. 2023:1–13.

Kabootari M, Hasheminia M, Azizi F, Mirbolouk M, Hadaegh F. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19(1):41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Onat A, Can G, Cicek G, Dogan Y, Yuksel H. Coronary disease risk and fasting glucose levels in a non-diabetic population. Diabetes Res Clin Pract. 2011;91(2):220–5.

Article  CAS  PubMed  Google Scholar 

Liberale L, Badimon L, Montecucco F, Lüscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2022;79(8):837–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vivek S, Carnethon MR, Prizment A, Carson AP, Bancks MP, Jacobs DR Jr., et al. Association of the extent of return to fasting state 2-hours after a glucose challenge with incident prediabetes and type 2 diabetes: the CARDIA study. Diabetes Res Clin Pract. 2021;180:109004.

Article  CAS  PubMed  PubMed Central  Google Scholar